Effect of Vibrant Capsule on Gastric Emptying and Antropyloroduodenal Motility in Healthy Volunteers
NCT02736799 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2024-08-15
Summary
The Vibrant capsule is a novel vibrating device for the treatment of gastrointestinal disorders. The effect of different vibrations on the motor functions of the gastrointestinal tract are unclear. The study will focus on the stomach in healthy volunteers.
The study will compare the effects of Vibrant capsule treatment and Sham capsule treatment on gastric emptying and gastric motility in healthy volunteers.
Conditions
Interventions
- DEVICE
-
Sham vibrating capsule
Sham device without vibration
- DEVICE
-
Vibrant Capsule (1 vibration)
1 vibration/min
- DEVICE
-
Vibrant Capsule (3 vibration)
3 vibration/min
- DEVICE
-
Vibrant Capsule (5 vibration)
5 vibration/min
Sponsors & Collaborators
-
Vibrant Ltd.
lead INDUSTRY
Principal Investigators
-
Michael Camilleri, MD · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Effect of the Motilin Receptor Agonist, Erythromycin, on Hunger and Food Intake; Study of Role of Cholinergic Pathways
NCT02633579 ·Status: COMPLETED ·Phase: NA
-
Effect of Metoclopramide Versus Erythromycin on on Gastric Residual Volume
NCT04682691 ·Status: COMPLETED ·Phase: NA
-
Study of Metoclopramide in Small Bowel Capsule Endoscopy
NCT01630109 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance
NCT01039805 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Methylnaltrexone on GI Transit in Healthy Volunteers
NCT01055704 ·Status: COMPLETED ·Phase: PHASE4
-
Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
NCT06464926 ·Status: RECRUITING ·Phase: NA
-
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
NCT01149369 ·Status: COMPLETED ·Phase: PHASE2
-
GPOEM Versus SHAM as a Treatement of Gastroparesis
NCT04552184 ·Status: UNKNOWN ·Phase: NA
-
Washed Microbiota Transplantation for Diabetic Gastroparesis
NCT06340217 ·Status: RECRUITING ·Phase: NA
-
Effect of ATI-7505 on Gastrointestinal Transit in Healthy Volunteers
NCT01094821 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety, PK and Efficacy of PCS12852 on Gastric Emptying Rate in Patients With Moderate to Severe Gastroparesis
NCT05270460 ·Status: COMPLETED ·Phase: PHASE2
-
Galvanic Vestibular Stimulation as a Novel Treatment for Seasickness
NCT05004818 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Electrical Neurostimulation in Cyclic Vomiting Syndrome.
NCT04721171 ·Status: TERMINATED ·Phase: NA
-
Bioavailability Study of Anti Nausea Medication With and Without Food (EUR-1025)
NCT00981487 ·Status: COMPLETED ·Phase: PHASE1
-
Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis
NCT04501211 ·Status: WITHDRAWN ·Phase: PHASE2
-
Metoclopramide on Gastric Emptying in Mechanically Ventilated Patients
NCT05641051 ·Status: COMPLETED ·Phase: PHASE4
-
VIBRANT Study of Vurolenatide in Adult Patients With Short Bowel Syndrome.
NCT04988997 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis
NCT04026997 ·Status: TERMINATED ·Phase: PHASE2
-
Preliminary Evaluation of an Osteopathic Manipulative Treatment (OMT) to Prevent Motion Sickness Symptoms
NCT05611814 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects.
NCT00733551 ·Status: COMPLETED ·Phase: PHASE1
-
Thumbtack Needle in the Treatment of NVP
NCT06566274 ·Status: RECRUITING ·Phase: NA
-
Noninvasive Markers of Functional Nausea in Children
NCT03593811 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040
NCT00562848 ·Status: COMPLETED ·Phase: PHASE1
-
Domperidone for the Treatment of Chronic Nausea and Vomiting Secondary to Gastroparesis
NCT01711918 ·Status: COMPLETED ·Phase: NA
-
Pgp Transporter and CNS Biodistribution of Ondansetron in Healthy Volunteers
NCT03809234 ·Status: TERMINATED ·Phase: PHASE1